Innovative Research Focus The Institute for Protein Innovation is at the forefront of protein science, providing synthetic antibodies and deep expertise to accelerate biomedical research, which creates opportunities for advanced laboratory tools, collaborations, and research services.

Recent Program Expansion With the launch of the Springer-Lu Postdoctoral Fellowship and the development of novel nanobody scaffolds, the institute demonstrates ongoing investment in cutting-edge antibody discovery technologies, signaling potential for partnerships in biotech and pharmaceutical applications.

Strategic Collaborations The partnership with Addgene enhances distribution of recombinant antibodies and protein reagents, presenting avenues to sell or co-develop bioreagents, and expanding market reach within the biomedical research community.

Funding and Revenue Growth Generating between $25 million and $50 million, the institute's substantial revenue stream indicates a strong market position, offering opportunities to introduce new products, tools, and services that complement their existing portfolio.

Leadership and Visibility Led by a prominent CEO and actively engaging in public communication, including social media platforms, the institute’s visibility offers prospects for brand partnerships, sponsored research, or grants aligned with their mission to improve human health through protein science.